Medication Safety

Industry Sponsor: 
AbbVie or Novartis

For more information, please see this brochure.

Program Details

AbbVie Fellowship
Purdue University, College of Pharmacy – Indianapolis, IN
During this 4-month rotation, the fellow will have unique experiences in academia, such as publishing original research, delivering presentations, and teaching. The fellow will actively participate in practice-based research to foster the discovery and delivery of information and practices to enhance medication safety.
 
AbbVie, Pharmacovigilance and Patient Safety – North Chicago, IL
During this 12-month rotation, the fellow at AbbVie will gain experience in safety signal detection and evaluation as well as the development of regulatory documents.
 
Food and Drug Administration, Division of Risk Management (DRISK) – Silver Spring, MD 
During this 8-month rotation, the fellow will participate in intra- and inter-center projects in pre- and post-market arenas. The fellow will focus on research opportunities to contribute to the review, development, modification, and assessment of a Risk Evaluation and Mitigation Strategy (REMS) for prescription drugs and biologics in accordance with the current FDA standards.
 
Novartis Fellowship
Not recruiting for the 2023-2025 cycle.

 

Program Staff


Kyle Hultgren, PharmD
Director, Center for Medication Safety Advancement
Clinical Assistant Professor of Pharmacy Practice, Purdue University College of Pharmacy
 
Dan Degnan, PharmD, MS, CPPS, FASHP
Associate Director for the Professional Program Laboratory
Clinical Assistant Professor of Pharmacy Practice (Courtesy)
Purdue University College of Pharmacy
 
Alissa Jara, PhD
Assistant Professor of Pharmacy Practice
Purdue University College of Pharmacy
 
Dorothy Linvill-Neal
Global Head, Name Creation & Regulatory Strategy
Novartis
 
Adrienne M. Rothstein, PharmD
Director, Safety Data Sciences, Pharmacovigilance and Patient Safety 
AbbVie
 
Alexandra Terry, PharmD, BCPS
Associate Director, Safety Data Sciences, Pharmacovigilance and Patient Safety
AbbVie
 
Charlotte Moureaud, PharmD, MBA
Associate Director, Safety Data Sciences, Pharmacovigilance and Patient Safety
AbbVie
 
Mishale Mistry, PharmD, MPH
Associate Director for Nomenclature and Labeling
Division of Medication Error Prevention and Analysis
U.S. Food and Drug Administration
 
Ashleigh Lowery, PharmD, BCCCP
Team Leader, Division of Medication Error Prevention and Analysis
U.S. Food and Drug Administration

 

Current Fellows


First-Year Fellows
  • 2022-2024: Michelle T. Le, PharmD
    Chapman University School of Pharmacy, Class of 2022
  • 2022-2024: Nikhila Viswanathan, PharmD, MS
    Temple University School of Pharmacy, Class of 2022
Second-Year Fellows
  • 2021-2023: Amy Bao, PharmD
    University of Maryland School of Pharmacy, Class of 2021
  • 2021-2023: Peter Kokkinias, PharmD
    Purdue University, Class of 2021

Past Fellows


2020-2022: Irene Lin, PharmD, MPH
Senior Safety Data Scientist
AbbVie
 
2020-2022: Morgan Nicolas, PharmD
Manager, Trial Capabilities
Eli Lilly and Company
 
2019-2021: Charlotte Moureaud, PharmD, MBA
Associate Director, Safety Data Sciences
AbbVie
 
2019-2021: Jonell Nwabueze, PharmD, MBA
Leadership Development Program
Eli Lilly and Company
 
2018-2020: Danya Faruqi, PharmD
Senior Safety Data Scientist
AbbVie
 
2017-2019: Kathryn K. Marwitz, PharmD, MPH
Assistant Professor of Pharmaceutical Sciences (Social and Administrative Sciences)
Manchester University College of Pharmacy, Natural & Health Sciences
 
2016-2018: Kaitlyn Dana Clari, PharmD
Project Planner, Associate Director
Pfizer, Groton, CT
 
2015-2016: Janelle R. Lenz, PharmD
Medical Science Liaison - Oncology
Lilly USA, LLC
 
2014-2015: Trang Truong
Director, Global Pharmacovigilance Scientist Lead
Amgen
 
2013-2015: Katelyn Brown, PharmD
Principal Research Scientist for Clinical Development
Eli Lilly and Company; Indianapolis, IN
 
2012-2013: Jaclyn A. Jeffries, PharmD, CPh, CPPS
Executive Director, Safety
AdventHealth
 

Benefits

  • Competitive stipend
  • Reimbursement for relocation during fellowship and professional travel expenses 
  • Enrollment in Indiana Pharmacy Teaching Certificate (IPTeC) Program
  • Optional Purdue University benefits package
    • Health insurance
    • Prescription coverage
    • Vision plan
    • Dental
  • Vacation and University holidays
     

Eligibility


The fellow must be a graduate from an ACPE-accredited college of pharmacy, or otherwise eligible for licensure as a pharmacist, prior to the start of the fellowship term. All applicants must be U.S. citizens to complete the program. Candidates who do not meet this requirement should not apply.
 

Application Process

 
All interested applicants must submit the following via the online portal:
  1. Letter of intent. Please specify track and sponsor(s) of interest.
  2. Contact information for three references, including name, email, and phone number. References will be contacted to submit a letter of recommendation through the online portal.
    1. AbbVie track requirement only: One reference must come from an active clinician (acute care, ambulatory, etc. - any site where this individual has a direct patient care mandate).
  3. Curriculum Vitae.
  4. Official transcripts. You may also send your transcripts directly to MedSafetyFellowship@purdue.edu.

Please address all fellowship application materials to the Pharmaceutical Regulatory Fellowship Program Director, Dr. Amy Sheehan. 

Candidates must submit separate applications for the AbbVie and Novartis tracks.

AbbVie Application Timeline:
All application materials should be submitted electronically to the online application portal no later than November 15th, 2022
Preliminary interviews will be conducted virtually on a rolling basis, starting November 1st, 2022
Final round interviews will take place virtually on November 28th/29th/30th, 2022
 
 

Recognizing that the choice of a Post-Doctoral Industry Fellowship is an important decision, Purdue University College of Pharmacy, in conjunction with the Academic Industry Fellowship Alliance (AIFA), has agreed to extend offers for Fellowships no earlier than December 7, 2022.  

  • The AIFA is comprised of Keck Graduate Institute (KGI), Massachusetts College of Pharmacy and Health Sciences (MCPHS), Northeastern University Pharmaceutical Industry Fellowships, Purdue University College of Pharmacy, Rutgers Institute for Pharmaceutical Industry Fellowships (RPIF), Saint Joseph’s University, University of North Carolina Division of Pharmacotherapy and Experimental Therapeutics (UNC, DPET), and University of Southern California School of Pharmacy (USC School of Pharmacy). 
We see this respect for candidate choice as a common aspect of each of our Program’s cultures. 
We hope that other academic and non-academic Fellowship Programs will respect this timeline. 

Contact Information


MedSafetyFellowship@purdue.edu
 

Mega Menu Visual Content